The size of the North America Enteral Feeding Devices Market was worth USD 0.77 billion in 2022 and estimated to be growing at a CAGR of 4.81%, to reach USD 0.97 billion by 2027. The growing geriatric population, higher immature births, and a more considerable prevalence of chronic diseases are the key factors driving the growth of the North America enteral feeding device market. The high incidence of preterm birth in emerging economies that continuously improves healthcare infrastructure, healthcare spending, and patient awareness levels are further accelerating the market.
The North American and European markets lead the global market for enteral feeding devices, with an overall market share of 67%. In recent years, the rapid growth of these markets may be due to increased awareness of enteral nutrition and the growing elderly population. In North America, the increasing trend toward home enteral care has reduced the number of visits to hospitals and clinics, and the use of enteral feeding equipment in the region has increased. The rising incidence of cancer and gastrointestinal disorders is foreseen to drive the North American market for enteral feeding devices.
The use of enteral feeding pumps is vital on this population basis and offers significant growth opportunities for market participants. It is also essential to recognize the effectiveness of such devices to distribute the right amount of nutrients. Enteral feeding pumps are of great interest throughout the hospital and home care environment because of their safety and the proper distribution of nutrients. North America held the largest market share of approximately 38% in revenue in 2018. It is due to several factors, such as the increased prevalence of lifestyle-related diseases and other disorders such as diabetes, autism, and cancer. Patients undergoing cosmetic surgery are also one of the big pools of such devices.
The high cost of devices and the high cost of installation are significant restraints in the growth of the North America Enteral Feeding Devices Market.
This research report on the North American Enteral Feeding Devices Market has been segmented and sub-segmented into the following categories:
By Product Type:
By End User:
Regionally, North America leads the global market with a share of about 35%. Highly advanced healthcare systems and the adoption of advanced, patient-friendly enteral feeding devices integrated with safety attributes are the main factors responsible for the large share of North America in the global enteral feeding devices market.
The United States enteral feeding device market holds the highest market share in this region due to increasing preterm births in this region. According to the WHO report in 2018, 1 in 10 babies or 10% were born preterm in this region. In the U.S., around 380000 are born prematurely annually. Besides, the increasing diabetics patient in this region increases the market growth. According to the US Centers for Disease Control and Prevention report, the number of patients with diabetics continues to grow, with around 12% of the adult population anticipated to have the disease. It is predicted to drive the growth of the market in this region.
Canada Enteral Feeding Devices Market
Canada is showing significant growth in the enteral feeding device market due to the increasing prevalence of lifestyle diseases and the increasing geriatric population. The older people have difficulty in consuming food and medications, and enteral feeding helps with this problem. Hence, the growth of the geriatric population in this region is anticipated to strongly influence the growth of the Canadian enteral feeding devices market.
Companies playing a dominant role in the North America Enteral Feeding Devices Market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE., Covidien PLC, Cook Medical, and Nestle S.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org